<DOC>
	<DOCNO>NCT02168205</DOCNO>
	<brief_summary>This study evaluate effect food smoking healthy old subject take pomalidomide .</brief_summary>
	<brief_title>Food Effect CYP1A2 Induction Study Healthy Subjects</brief_title>
	<detailed_description>This study conduct two part . Parts 1 2 may conduct parallel subject allow participate one part . In Part 1 , subject randomly assign receive single oral dose 4 mg pomalidomide Day 1 fed ( standard high fat breakfast ) fast condition . After washout period least 3 7 day , subject receive single oral dose 4 mg pomalidomide opposite condition receive first period . In Part 2 , healthy male smoker subject must smoke approximately 20 cigarette per day total 10 day . Non-smokers neither smoke presence smoker . All subject receive orally 200-mg caffeine capsule Day 6 , Day 8 , subject receive single oral dose 4 mg pomalidomide . For Parts 1 2 , serial blood sample collect determination plasma pomalidomide concentration .</detailed_description>
	<mesh_term>Pomalidomide</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<criteria>Part 1 : 1.Must understand voluntarily sign write Informed Consent prior studyrelated procedure perform . 2.Must able communicate Investigator , understand comply requirement study , agree adhere restriction examination schedule . 3.Must male postmenopausal* woman race ≥61 ≤85 year age ( inclusive ) time sign Informed Consent , good health determine physical exam , clinical laboratory safety test result , vital sign , 12 lead Electrocardiogram . * =Naturally postmenopausal least 24 consecutive month ( ie , menses time precede 24 consecutive month ) 4.Subjects must non smoker . 5.Clinical laboratory test must within normal limit acceptable Principal Investigator ( PI ) . 6.Must normal clinically acceptable 12lead Electrocardiogram . 7.Must afebrile ( febrile define ≥ 38.0ºC 100.4 Fahrenheit ) , supine systolic blood pressure ( BP ) : 90 150 mmHg , supine diastolic blood pressure : 60 95 mmHg , pulse rate : 40 110 bpm control medication indicate ( especially blood pressure ) . 1 . If subject diagnosis hypertension , range BP pulse rate one consider well control medication . 8.Must practice true abstinence* agree use condom sexual contact pregnant female female get pregnant participating study , dose interruption least 28 day follow study drug discontinuation , even undergone successful vasectomy . * = True abstinence acceptable line prefer usual lifestyle subject . Period abstinence ( e.g. , calendar , ovulation , symptothermal , post ovulation method ) withdrawal acceptable method contraception 9.Must agree refrain donate sperm semen participate study least 28 day follow last dose study drug . 10.Must agree refrain donate blood plasma ( study ) participate study least 28 day follow last dose study drug . 11.Must agree comply condition describe counsel document ( part pomalidomide Pregnancy Prevention Risk Management Plan . Part 2 1 . Must understand voluntarily sign write informed consent prior studyrelated procedure perform . 2 . Must able communicate Investigator , understand comply requirement study , agree adhere restriction examination schedule . 3 . Must male race 40 80 year age ( inclusive ) time sign Informed Consent , good health determine physical exam , clinical laboratory safety test result , vital sign , 12 lead electrocardiogram . 4 . Cohort A subject ( smoker ) must history smoking &gt; 5 year currently smoke ≥1 pack ( 2025 ) cigarette per day ; urine cotinine level screen baseline ( Day 1 ) indicate subject heavy smoker . 5 . Cohort B subject ( nonsmoker ) must smoke &gt; 5 year ( Cohort B ) . 6 . Clinical laboratory test must within normal limit acceptable Principal Investigator . 7 . Must normal clinically acceptable 12lead Electrocardiogram , QTcF value ≤ 450 msec . 8 . Must afebrile ( febrile define ≥ 38.0ºC 100.4 Fahrenheit ) , supine systolic blood pressure ( BP ) : 90 150 mmHg , supine diastolic blood pressure : 60 95 mmHg , pulse rate : 40 110 bpm control medication indicate ( especially blood pressure ) . 9 . Must practice true abstinence agree use condom sexual contact pregnant female female get pregnant participating study , dose interruption least 28 day follow study drug discontinuation , even undergone successful vasectomy . 10 . Must agree refrain donate sperm semen participate study least 28 day follow last dose study drug . 11 . Must agree refrain donate blood plasma ( study ) participate study least 28 day follow last dose study drug . 12 . Must agree comply condition describe counsel document ( part pomalidomide Pregnancy Prevention Risk Management Plan . Both Parts : 1 . History clinically significant relevant neurological , gastrointestinal , renal , hepatic , cardiovascular , psychological , pulmonary , metabolic , endocrine , hematological , allergic disease , drug allergy , know hypersensitivity member class drug modulate immune system , major disorder . 1 . Subjects wellcontrolled hypertension , hyperlipidemia , gout , asthma/chronic obstructive pulmonary disease , hypothyroidism common agerelated disorder , require treatment wellcontrolled concomitant prescription medication ( ) eligible inclusion study . 2 . Subjects diabetes , significant gastrointestinal disease hematologic disorder include study . 2 . Any condition , include presence laboratory abnormality , place subject unacceptable risk participate study , confound ability interpret data study . 3 . Used prescribed systemic topical medication within 30 day first dose administration , unless medication chronically administer Sponsor agreement obtain . 4 . Used nonprescribed systemic topical medication ( include vitamin/mineral supplement , herbal medicine ) within 14 day first dose administration , unless medication chronically administer Sponsor agreement obtain . 5 . Has surgical medical condition possibly affect drug absorption , distribution , metabolism excretion , e.g. , bariatric procedure . 6 . Donated blood plasma within 8 week first dose administration blood bank blood donation center . 7 . History drug abuse ( define current version Diagnostic Statistical Manual within 2 year dose , positive drug screen test reflect consumption illicit drug . 8 . History alcohol abuse ( define current version DSM ) within 2 year dose , positive alcohol screen . 9 . Known serum hepatitis know carrier hepatitis B surface antigen , hepatitis C antibody , positive result test Human Immunodeficiency Virus antibodies Screening . 10 . Exposed investigational drug ( new chemical entity ) within 30 day precede first dose administration , 5 halflives investigational drug , know ( whichever longer ) . 11 . Received vaccination ( exclude seasonal flu vaccination ) within 90 day study drug administration . 12 . Subjects part staff personnel family member investigational study staff .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pomalyst</keyword>
	<keyword>Pomalidomide</keyword>
	<keyword>Food effect</keyword>
	<keyword>smoker</keyword>
</DOC>